The VNGOC together with NYNGOC and the UNODC Civil Society Unit is organizing an online side event in the margins of the 2023 ECOSOC Partnership Forum on 31 January 2023 at 8.30 AM. The event is titled: The central role of civil society in drug policies, COVID-19 and achieving the 2030 Agenda

Mid-America Addiction Technology Transfer Center (MATTC) partnered with the Ethnic Communities Opioid Response Network in Missouri, the Addiction Policy Forum, and the Opioid Response Network (ORN in IA, KS, MO, and NE) to translate 5 different evidence-based prevention products "Prevention of Opioid Use Education Materials"  into 12 different languages, and ensure they are culturally appropriate, including Arabic, Bosnian, Burmese, Dari, French, Mandarin Chinese, Pashto, Somali, Spanish, Swahili, Tagalog (Filipino) and Ukrainian.

INTRODUCTION:

Screening and brief interventions (SBI) consist of a variety of activities aimed at people who engage in risky alcohol drinking, but who are not severely alcohol-dependent. Many studies have proved that SBI might serve as a very effective tool for reducing alcohol consumption and the associated negative consequences. However, the rate of SBI provided by healthcare professionals in the Czech Republic is relatively low. Our aim is to perform a quantified economic evaluation of SBI in the Czech Republic and thus point out its high importance in the field of alcohol policy.

METHODS

Brief Description:

The Executive Secretariat of the Inter-American Drug Abuse Control Commission (ES-CICAD) is seeking expressions of interest from experts in the field of alternatives to incarceration and social integration to be trained as Master Trainers for the delivery of the Case Care Management curriculum internationally. Upon successful completion of the Training of Trainers, these Master Trainers will be included on the Case Care Management roster of trainers and can be contacted to deliver the training when scheduled. If interested, please submit your resume and relevant information...

This document, ‘The International Standards for the Treatment of Drug Use Disorders' is the work of UNODC and WHO to support Member States in their efforts to develop
and expand effective, evidence-based and ethical treatment for drug use disorders.

The Standards are intended for all those involved in the policy development, planning, funding, delivery, monitoring and evaluation of treatment services and interventions for drug use disorders.

This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of...

Dear friends and colleagues, 

The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022. 

Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing about that means that, you can still follow the plenaries and the side events! That’s why we thought that you might appreciate having all the links in one place.

GENERAL LINKS TO FOLLOW CND

• Link to 65th session with general information on organizational arrangements: https://www.unodc.org/unodc/en/commissions/CND/session/65_Session_2022/65CND_Main...

Hybrid effectiveness-implementation trial designs have become increasingly prevalent in implementation research. As hybrid designs enter their second decade of widespread use, the Frontiers in Health Services’ Implementation Science section launches a Research Topic to fuel the field’s discourse on the past, present, and future of hybrid designs in knowledge translation. Submissions are welcome of both Original and/or Brief Research, Review, Methods, and Perspective articles. The call addresses critical assessments of hybrid designs, innovative use of hybrid designs in current trials, and...

COVID-19 (SARS-CoV-2) was classified a pandemic on March 11, 2020, with early reports of the disease occurring in the Middle East and North African (MENA) area. On January 2021, the World Health Organization Eastern Mediterranean Regional Office (WHO-EMRO) reported 5,566,708 confirmed cases with 131,886 fatalities to date. Since 2016, the Middle East and North Africa (MENA) area has seen a modest but steady growth in the harm reduction response.

Little is known about the region's health response and the situation of drug users (PWUD) during the outbreak. During COVID-19, the MENA Harm...